[go: up one dir, main page]

AU8762991A - Human papilloma viral protein expression for use in vaccine compositions - Google Patents

Human papilloma viral protein expression for use in vaccine compositions

Info

Publication number
AU8762991A
AU8762991A AU87629/91A AU8762991A AU8762991A AU 8762991 A AU8762991 A AU 8762991A AU 87629/91 A AU87629/91 A AU 87629/91A AU 8762991 A AU8762991 A AU 8762991A AU 8762991 A AU8762991 A AU 8762991A
Authority
AU
Australia
Prior art keywords
protein expression
vaccine compositions
viral protein
human papilloma
papilloma viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU87629/91A
Inventor
James Blake
Lieping Chen
Ingegerd Hellstrom
Karl Erik Hellstrom
Shiu-Lok Hu
Elaine Kinney Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of AU8762991A publication Critical patent/AU8762991A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/084—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU87629/91A 1990-09-26 1991-09-26 Human papilloma viral protein expression for use in vaccine compositions Abandoned AU8762991A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58838490A 1990-09-26 1990-09-26
US588384 1990-09-26

Publications (1)

Publication Number Publication Date
AU8762991A true AU8762991A (en) 1992-04-15

Family

ID=24353621

Family Applications (1)

Application Number Title Priority Date Filing Date
AU87629/91A Abandoned AU8762991A (en) 1990-09-26 1991-09-26 Human papilloma viral protein expression for use in vaccine compositions

Country Status (4)

Country Link
CN (1) CN1067382A (en)
AU (1) AU8762991A (en)
TW (1) TW221691B (en)
WO (1) WO1992005248A1 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0523391B1 (en) * 1991-07-13 2003-03-19 Dade Behring Marburg GmbH Use of HPV-16 E6 and E7-gene derived peptides for the diagnostic purpose
GB9207701D0 (en) * 1992-04-08 1992-05-27 Cancer Res Campaign Tech Papillomavirus e7 protein
IL105554A (en) * 1992-05-05 1999-08-17 Univ Leiden Peptides of human papilloma virus for use in human t cell response inducing compositions
GB9306731D0 (en) * 1993-03-31 1993-05-26 Cancer Res Campaign Tech Vaccines
US6013517A (en) 1994-05-09 2000-01-11 Chiron Corporation Crossless retroviral vectors
CA2158977A1 (en) 1994-05-09 1995-11-10 James G. Respess Retroviral vectors having a reduced recombination rate
AUPN015794A0 (en) * 1994-12-20 1995-01-19 Csl Limited Variants of human papilloma virus antigens
WO1996026277A1 (en) * 1995-02-24 1996-08-29 Cantab Pharmaceuticals Research Limited Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation
AUPN443995A0 (en) * 1995-07-27 1995-08-17 Csl Limited Papillomavirus polyprotein
CZ28899A3 (en) * 1996-07-29 1999-07-14 Cantab Pharmaceuticals Research Limited Polypeptides usable as immunotherapeutic agents and processes for preparing polypeptides
GB9717953D0 (en) * 1997-08-22 1997-10-29 Smithkline Beecham Biolog Vaccine
DE19925199A1 (en) 1999-06-01 2000-12-07 Medigene Ag Cytotoxic T cell epitopes of the papillomavirus L1 protein and their use in diagnostics and therapy
DE19925235A1 (en) 1999-06-01 2000-12-07 Medigene Ag Cytotoxic T cell epitopes of the papillomavirus L1 protein and their use in diagnostics and therapy
AU2007201619B2 (en) * 1999-09-16 2011-05-12 Eisai Inc. Nucleic acids encoding polyepitope polypeptides
DK1214097T3 (en) * 1999-09-16 2009-11-16 Eisai Corp North America Nucleic acids encoding polyepitope polypeptides
US8128922B2 (en) 1999-10-20 2012-03-06 Johns Hopkins University Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
WO2002012281A2 (en) 2000-08-03 2002-02-14 Johns Hopkins University Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
WO2004024915A1 (en) * 2002-09-13 2004-03-25 The University Of Queensland Gene expression system based on codon translation efficiency
US9701725B2 (en) 2003-05-05 2017-07-11 The Johns Hopkins University Anti-cancer DNA vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
CA2594040A1 (en) 2005-01-06 2006-07-13 The Johns Hopkins University Rna interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by dna and transfected dendritic cell vaccines
CA2595726A1 (en) * 2005-01-26 2006-08-03 The Johns Hopkins University Anti-cancer dna vaccine employing plasmids encoding mutant oncoprotein antigen and calreticulin
US9085638B2 (en) 2007-03-07 2015-07-21 The Johns Hopkins University DNA vaccine enhancement with MHC class II activators
TWI376385B (en) 2007-12-07 2012-11-11 Nat Health Research Institutes Production of lipidated proteins in e. coli
US8466259B2 (en) 2007-12-07 2013-06-18 National Health Research Institutes Adjuvants
US8287880B2 (en) 2009-06-02 2012-10-16 National Health Research Institutes Lipidated vaccine against dengue virus infection
CN102482327B (en) 2009-06-22 2014-10-29 财团法人卫生研究院 Lipidated tumor-associated antigen and composition and method for immunotherapy thereof
TWI507413B (en) 2010-11-15 2015-11-11 Nat Health Research Institutes Lipidated polyepitope vaccines
TW201221642A (en) 2010-11-15 2012-06-01 Nat Health Research Institutes Method of producing lipidated polypeptides
CN114277038A (en) * 2011-10-12 2022-04-05 宾夕法尼亚大学理事会 Vaccines for human papillomavirus and methods of use
BR112015021974A2 (en) 2013-03-12 2017-08-29 The Trustees Of The Univ Of Pennsylvania E Inovio Pharmaceuticals Inc COMPOSITION AND METHOD OF INDUCING AN IMMUNE RESPONSE
MX2017011732A (en) * 2015-03-18 2018-08-15 Omnicyte Fusion proteins comprising modified alpha virus surface glycoproteins and tumor associated antigen and methods thereof.
EP3645562A1 (en) * 2017-06-28 2020-05-06 Regeneron Pharmaceuticals, Inc. Anti-human papillomavirus (hpv) antigen-binding proteins and methods of use thereof

Also Published As

Publication number Publication date
TW221691B (en) 1994-03-11
WO1992005248A1 (en) 1992-04-02
CN1067382A (en) 1992-12-30

Similar Documents

Publication Publication Date Title
AU8762991A (en) Human papilloma viral protein expression for use in vaccine compositions
AU6997291A (en) Skin care compositions
EP0451550A3 (en) Seroreactive epitopes of human papillomavirus (hpv) 16 proteins
HK1000113A1 (en) Vaccine composition
AU8039591A (en) Gel formulations
LTIP335A (en) Vaccine for human immunodeficiency virus
AU5561690A (en) Improvements in or relating to pharmaceutical preparations
AU7621291A (en) Seroreactive epitopes on proteins of human papillomavirus (HPV) 18
AU7668591A (en) Disposable right angle dental handpiece
NZ240369A (en) Muramyl dipeptide derivatives and vaccine compositions
IL113484A0 (en) Viral proteins pharmaceutical compositions containing them their preparation and use
AU4899690A (en) Hair care compositions
AU5252090A (en) Improvements in and relating to pharmaceutical formulations
AU5836390A (en) Human lymphoma-associated virus
GR3019065T3 (en) Vaccine Composition
AU8235291A (en) Lyophilized native collagen sheets comprising cosmetic formulations for the treatment of couperose
AU1173892A (en) Compositions for use in dentistry
AU4310689A (en) Virus-derived antigenic composition and its preparation and use
AU5351590A (en) Dental preparation
AU1676288A (en) Human immunodeficiency virus gag-encoded proteins
AU5217890A (en) Monoclonal antibodies in vaccine formulations
AU8856891A (en) Dental implement
GB9013878D0 (en) Novel benzothiazepine esters,their preparation and formulations for therapeutic use
AU9034791A (en) Improvements relating to chairs
AU640364C (en) Vaccine composition